During Q4 2018 the big money sentiment increased to 1.48. That’s change of 0.57, from 2018Q3’s 0.91. 20 investors sold all, 46 reduced holdings as Select Medical Holdings Corporation ratio is positive. 65 grew positions while 33 funds acquired positions. Funds hold 102.60 million shares thus 1.62% more from 2018Q3’s 100.97 million shares.
Menta Limited Liability Com holds 10,531 shs. Timessquare Cap Mngmt Ltd Liability invested 0.25% in Select Medical Holdings Corporation (NYSE:SEM). Clarivest Asset Lc has invested 0.03% in Select Medical Holdings Corporation (NYSE:SEM). Texas Permanent School Fund invested in 70,848 shs. Cwm Limited Liability Corporation invested 0% of its capital in Select Medical Holdings Corporation (NYSE:SEM). Art Advsr Lc holds 0.05% of its capital in Select Medical Holdings Corporation (NYSE:SEM) for 47,400 shs. Parallax Volatility Advisers L P holds 0% or 30,088 shs. Gam Ag owns 20,652 shs or 0.02% of their US capital. 1,542 are held by Glenmede Tru Na. James Research Inc has invested 0.06% in Select Medical Holdings Corporation (NYSE:SEM). Lpl Fincl Ltd Liability Corp holds 0% or 10,980 shs in its capital. Jefferies Grp Incorporated Ltd Co owns 0% invested in Select Medical Holdings Corporation (NYSE:SEM) for 14,913 shs. New York-based Alliancebernstein L P has invested 0% in Select Medical Holdings Corporation (NYSE:SEM). Par Capital Management reported 0.15% stake. Ameritas Inv Prns has 9,219 shs.

Today Select Medical Holdings Corporation (NYSE:SEM) with $13.78 share price, touched 1-year low with $12.82 price target or 7.00 % below. It was reported on Mar, 9 according to Barchart.com. The company has $1.86B market cap. At $12.82 stock price target, the company valuation changes by $130.48 million less.

SEM is touching $13.78 during the last trading session, after increased 0.15%.Currently Select Medical Holdings Corporation is downtrending after 17.54% change in last March 9, 2018. SEM has 585,026 shares volume. SEM underperformed the S&P500 by 21.91%.

On May, 2 Select Medical Holdings Corporation (NYSE:SEM)’s earnings release is anticipated by WallStreet, according to Faxor. Analysts predict $0.27 earnings per share. That’s $0.02 down or 6.90 % from 2018’s earnings of $0.29. If reported the P/E will be 12.76 with $36.52M profit. Last quarter $0.20 earnings per share was reported. Analysts forecasts 35.00 % EPS growth this quarter.

Select Medical Holdings Corporation (NYSE:SEM) Ratings Coverage

In total 3 analysts cover Select Medical Holdings (NYSE:SEM). “Buy” rating has 1, “Sell” are 0, while 2 are “Hold”. 33% are bullish. 5 are the (NYSE:SEM)’s analyst reports since October 16, 2018 according to StockzIntelligence Inc. On Monday, November 5 the rating was maintained by Credit Suisse with “Neutral”. On Monday, February 25 the firm earned “Buy” rating by RBC Capital Markets. On Monday, January 7 the stock of Select Medical Holdings Corporation (NYSE:SEM) has “Neutral” rating given by Credit Suisse.

For more Select Medical Holdings Corporation (NYSE:SEM) news released briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Bizjournals.com. The titles are as follows: “Select Medical sees almost $1.3B in Q3 revenue – Seeking Alpha” released on October 10, 2018, “Select Medical Holdings Corporation (SEM) on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” on August 03, 2018, “Select Medical Holdings Corporation (SEM) Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” with a publish date: November 02, 2018, “Select Medical misses by $0.02, misses on revenue – Seeking Alpha” and the last “Bankruptcy judge OKs sale of 3 Florida hospitals for $63M – South Florida Business Journal” with publication date: March 01, 2019.

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the United States.The firm is valued at $1.86 billion. The company's Specialty Hospitals segment operates long term acute care hospitals and inpatient acute rehabilitative hospitals.The P/E ratio is 13.51. This segment offers various medical services for the treatment of respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders, and cancer.